NCT01800799View on ClinicalTrials.gov

Urinary NGF as A Biomarker for Acute Bacterial Cystitis

NACompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Urinary Tract Infection
Interventions
DRUG

Baktar 800mg h.s.

Antimicrobial agent (Baktar 800mg h.s.)

DRUG

Celecoxib 200mg QD

Anti-inflammatory agent (Celecoxib 200mg QD)

Trial Locations (1)

970

Buddhist Tzu Chi General Hospital, Hualien City

All Listed Sponsors
lead

Buddhist Tzu Chi General Hospital

OTHER

NCT01800799 - Urinary NGF as A Biomarker for Acute Bacterial Cystitis | Biotech Hunter | Biotech Hunter